← Evidence map

ArticleDiscover oncology2025

MUC3A promotes the progression of cholangiocarcinoma through the MAPK/ERK pathway.

Baijie Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40198406